title: Single-tablet antiretroviral treatment (once daily).
authors.affiliation: Department of Medicine (Andany, Gold), University of Toronto; Division of Infectious Diseases (Gold), University Health Network, Toronto, Ont.
authors.forename: Nisha
authors.initials: N
authors.lastname: Andany
authors.affiliation: Department of Medicine (Andany, Gold), University of Toronto; Division of Infectious Diseases (Gold), University Health Network, Toronto, Ont. wayne.gold@uhn.ca.
authors.forename: Wayne L
authors.initials: WL
authors.lastname: Gold
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015224:Dideoxynucleosides / Q000627:therapeutic use; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000209:etiology; D004347:Drug Interactions; D024882:Drug Resistance, Viral; D000068257:Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination / Q000627:therapeutic use*; D000069545:Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination / Q000627:therapeutic use*; D000068678:Emtricitabine, Rilpivirine, Tenofovir Drug Combination / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006575:Heterocyclic Compounds, 3-Ring / Q000627:therapeutic use; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D001523:Mental Disorders / Q000139:chemically induced; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D019562:Viral Load; D000099227:Abacavir; D000099226:Dolutegravir
chemical_list: D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D004338:Drug Combinations; D000068257:Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D000069545:Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D000068678:Emtricitabine, Rilpivirine, Tenofovir Drug Combination; D006575:Heterocyclic Compounds, 3-Ring; D019259:Lamivudine; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099227:Abacavir; D000099226:Dolutegravir